The 2nd International Conference on Drug Discovery & Therapy: Dubai, February 1 - 4, 2010


Invited Speaker

Silicon-Based Protease Inhibitors – Advances in Chemistry and Applications
Scott McN. Sieburth
USA

The silanediol group, when incorporated into a peptide-like structure (1), can be an effective mimic of the tetrahedral intermediate of amide hydrolysis (6) and thereby act as an inhibitor of proteolytic enzymes. Appropriately functionalized silanediol structures have been found to be low nanomolar inhibitors of aspartic and metallo- proteases.1 Inhibition of serine proteases is a focus of our current efforts.



Instrumental to the exploration and use of silanediol inhibitors is an efficient method for their assembly. The first synthetic methods were linear and labor intensive. We are developing short asymmetric sequences using readily available components (2 – 4), employing both asymmetric catalysis and chiral auxiliary-based methods, to fully control the stereochemistry in both the -amino silane component (blue) and -silyl acid portion (magenta). The state-of-the-art in silanediol protease inhibitor synthesis and applications will be described.

1.S. McN. Sieburth & C.-A. Chen, "Silanediol Protease Inhibitors: From Conception to Validation" Eur. J. Org. Chem. 2006, 311-22.













[Webmaster]   Copyright © 2010 2nd International Conference on Drug Design & Therapy